Table 1 Baseline characteristics of the cohort
|  | Non-metformin N = 48 | Metformin N = 55 | p-value |
|---|---|---|---|
Recipient age (years) (mean ± SD) | 53 ± 11 | 54 ± 9 | 0.503 |
Donor age (years) (mean ± SD) | 35 ± 13 | 33 ± 12 | 0.715 |
Recipient gender (male) (%) | 42 (87) | 47 (85) | 0.989 |
Donor gender (male) (%) | 23 (66) | 29 (71) | 0.825 |
Etiology (ischemic) (%) | 38 (81) | 35 (64) | 0.089 |
Recipient BMI (kg/m2) (mean ± SD) | 31 ± 33 | 27 ± 4 | 0.365 |
Donor BMI (kg/m2) (mean ± SD) | 26 ± 5 | 27 ± 5 | 0.263 |
Hypertension (%) | 27 (56) | 36 (65) | 0.451 |
Dyslipidemia (%) | 28 (60) | 43 (78) | 0.069 |
Past smoker (%) | 24 (50) | 31 (56) | 0.654 |
Assist device (%) | 5 (10) | 11 (20) | 0.268 |
Status 1 (%) | 26 (54) | 29 (53) | 1.000 |
PRA > 30% (%) | 0 (0) | 1 (2) | 1.000 |
Recipient blood type (%) | Â | Â | 0.664 |
 A | 14 (41) | 12 (32) |  |
 AB | 5 (15) | 4 (10) |  |
 B | 5 (15) | 9 (24) |  |
 O | 10 (29) | 13 (34) |  |
Recipient creatinine | 1.5 ± 1.4 | 1.4 ± 0.6 | 0.524 |
Recipient bilirubin | 1.7 ± 3.4 | 1.2 ± 0.9 | 0.317 |
Immunosuppression (%) | Â | Â | 0.053 |
 1 | 38 (79) | 31 (57) |  |
 2 | 10 (21) | 22 (41) |  |
 3 | 0 (0) | 1 (2) |  |
Ischemic time (min) (mean ± SD) | 149 ± 39 | 165 ± 39 | 0.118 |
PAM (mmHg) (mean ± SD) | 29 ± 12 | 27 ± 13 | 0.382 |
CO (mean ± SD) | 3.6 ± 1 | 3.6 ± 1.1 | 0.972 |
PVR (mean ± SD) | 3.1 ± 1.8 | 2.7 ± 1.6 | 0.394 |
CMV mismatch (%) | 8 (29) | 7 (26) | 1.000 |
Statins post-HT (%) | 46 (96) | 53 (96) | 1.000 |
Hypertension post-HT (%) | 47 (98) | 51 (93) | 0.446 |